May 24, 2011 -- Analab Clinical Research, Inc., a early phase clinical conduct research company, announced the opening of their new Phase I/II facility in Lenexa, Kansas. The company focuses on normal healthy and special population studies and employs advanced clinical conduct business rules to promote safety, efficiency and high quality data results.